Irene Olabode, DO
Family Medicine · Atlanta, GANPI 1619297744
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 11.5% — the pattern of someone who eats at a lot of different presentations.
Across 85 payments — averaging $14.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$144
- Amgen$119
- Merck$117
- Amarin Pharma, Inc.$104
- Sanofi-aventis U.S. LLC$98
- AstraZeneca$86
- plus $583 from 15 others
What the payments were for
- Food & beverage$1,252100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $144 |
| Amgen | 7 | $119 |
| Merck | 13 | $117 |
| Amarin Pharma, Inc. | 5 | $104 |
| Sanofi-aventis U.S. LLC | 7 | $98 |
| AstraZeneca | 6 | $86 |
| Novartis | 4 | $71 |
| Astellas Pharma US Inc | 3 | $70 |
| Pfizer | 5 | $69 |
| Boehringer Ingelheim | 3 | $60 |
| Arbor Pharmaceuticals, Inc. | 4 | $56 |
| GSK | 3 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| AbbVie | 2 | $28 |
| Johnson & Johnson | 2 | $27 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Neotract Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$1,252 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 37 | $220 |
| Atorvastatin Calcium | 23 | $148 |
| Simvastatin | 12 | $133 |
| Losartan Potassium | 17 | $124 |
| Omeprazole | 11 | $113 |
| Hydrochlorothiazide | 12 | $33 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Atlanta
- Contessa MetcalfeAtlanta$157K
- Mark TannerAtlanta$94K
- Zazi NylanderAtlanta$35K
- Zia AbdiAtlanta$27K
- Donell CollinsAtlanta$19K
- Lauren PowellAtlanta$16K
- Jeffrey KingsleyColumbus$404K
- Debbie HaginsSavannah$279K
- Yolanda WadeTyrone$233K
- Julian HutchinsWarrenton$222K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.